These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 10420171)

  • 1. Discovery of novel peptidic dopamine transporter ligands by screening a positional scanning combinatorial hexapeptide library.
    Rothman RB; Baumann MH; Dersch CM; Appel J; Houghten RA
    Synapse; 1999 Sep; 33(3):239-46. PubMed ID: 10420171
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies of the biogenic amine transporters. V. Demonstration of two binding sites for the cocaine analog [125I]RTI-55 associated with the 5-HT transporter in rat brain membranes.
    Silverthorn ML; Dersch CM; Baumann MH; Cadet JL; Partilla JS; Rice KC; Carroll FI; Becketts KM; Brockington A; Rothman RB
    J Pharmacol Exp Ther; 1995 Apr; 273(1):213-22. PubMed ID: 7714769
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies of the biogenic amine transporters. IV. Demonstration of a multiplicity of binding sites in rat caudate membranes for the cocaine analog [125I]RTI-55.
    Rothman RB; Cadet JL; Akunne HC; Silverthorn ML; Baumann MH; Carroll FI; Rice KC; de Costa BR; Partilla JS; Wang JB
    J Pharmacol Exp Ther; 1994 Jul; 270(1):296-309. PubMed ID: 8035327
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies of the biogenic amine transporters. VII. Characterization of a novel cocaine binding site identified with [125I]RTI-55 in membranes prepared from human, monkey and guinea pig caudate.
    Rothman RB; Silverthorn ML; Glowa JR; Matecka D; Rice KC; Carroll FI; Partilla JS; Uhl GR; Vandenbergh DJ; Dersch CM
    Synapse; 1998 Apr; 28(4):322-38. PubMed ID: 9517841
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies of the biogenic amine transporters. VI. Characterization of a novel cocaine binding site, identified with [125I]RTI-55, in membranes prepared from whole rat brain minus caudate.
    Rothman RB; Silverthorn ML; Baumann MH; Goodman CB; Cadet JL; Matecka D; Rice KC; Carroll FI; Wang JB; Uhl GR
    J Pharmacol Exp Ther; 1995 Jul; 274(1):385-95. PubMed ID: 7616423
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies of the biogenic amine transporters. VIII: identification of a novel partial inhibitor of dopamine uptake and dopamine transporter binding.
    Rothman RB; Dersch CM; Carroll FI; Ananthan S
    Synapse; 2002 Mar; 43(4):268-74. PubMed ID: 11835522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies of the biogenic amine transporters. 10. Characterization of a novel cocaine binding site in brain membranes prepared from dopamine transporter knockout mice.
    Rothman RB; Carroll FI; Morales M; Rowley DL; Rice KC; Dersch CM; Donovan DM
    Synapse; 2002 May; 44(2):94-105. PubMed ID: 11891881
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple binding sites for [125I]RTI-121 and other cocaine analogs in rat frontal cerebral cortex.
    Boja JW; Carroll FI; Vaughan RA; Kopajtic T; Kuhar MJ
    Synapse; 1998 Sep; 30(1):9-17. PubMed ID: 9704876
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Direct approach for attenuating cocaine's effects on extracellular dopamine: targeting the dopamine transporter.
    Morgan AE; Porter SP; Clarkson FA; Volkow ND; Fowler JS; Dewey SL
    Synapse; 1997 Aug; 26(4):423-7. PubMed ID: 9215601
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of a tropane radioligand, [(3)H]2beta-propanoyl-3beta-(4-tolyl) tropane ([(3)H]PTT), for dopamine transport sites in rat brain.
    Letchworth SR; Smith HR; Porrino LJ; Bennett BA; Davies HM; Sexton T; Childers SR
    J Pharmacol Exp Ther; 2000 May; 293(2):686-96. PubMed ID: 10773045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-affinity binding of [125I]RTI-55 to dopamine and serotonin transporters in rat brain.
    Boja JW; Mitchell WM; Patel A; Kopajtic TA; Carroll FI; Lewin AH; Abraham P; Kuhar MJ
    Synapse; 1992 Sep; 12(1):27-36. PubMed ID: 1411961
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regional differences in extracellular dopamine and serotonin assessed by in vivo microdialysis in mice lacking dopamine and/or serotonin transporters.
    Shen HW; Hagino Y; Kobayashi H; Shinohara-Tanaka K; Ikeda K; Yamamoto H; Yamamoto T; Lesch KP; Murphy DL; Hall FS; Uhl GR; Sora I
    Neuropsychopharmacology; 2004 Oct; 29(10):1790-9. PubMed ID: 15226739
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prolonged dopamine and serotonin transporter inhibition after exposure to tropanes.
    Bennett BA; Hollingsworth CK; Martin RS; Childers SR; Ehrenkaufer RE; Porrino LJ; Davies HM
    Neuropharmacology; 1998; 37(1):123-30. PubMed ID: 9680265
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kappa-opioid receptor activation modifies dopamine uptake in the nucleus accumbens and opposes the effects of cocaine.
    Thompson AC; Zapata A; Justice JB; Vaughan RA; Sharpe LG; Shippenberg TS
    J Neurosci; 2000 Dec; 20(24):9333-40. PubMed ID: 11125013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies of the biogenic amine transporters 15. Identification of novel allosteric dopamine transporter ligands with nanomolar potency.
    Rothman RB; Ananthan S; Partilla JS; Saini SK; Moukha-Chafiq O; Pathak V; Baumann MH
    J Pharmacol Exp Ther; 2015 Jun; 353(3):529-38. PubMed ID: 25788711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lack of cocaine effect on dopamine clearance in the core and shell of the nucleus accumbens of dopamine transporter knock-out mice.
    Budygin EA; John CE; Mateo Y; Jones SR
    J Neurosci; 2002 May; 22(10):RC222. PubMed ID: 12006604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Voltammetric assessment of dopamine clearance in the absence of the dopamine transporter: no contribution of other transporters in core or shell of nucleus accumbens.
    Mateo Y; Budygin EA; John CE; Banks ML; Jones SR
    J Neurosci Methods; 2004 Dec; 140(1-2):183-7. PubMed ID: 15589348
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characteristics of drug interactions with recombinant biogenic amine transporters expressed in the same cell type.
    Eshleman AJ; Carmolli M; Cumbay M; Martens CR; Neve KA; Janowsky A
    J Pharmacol Exp Ther; 1999 May; 289(2):877-85. PubMed ID: 10215666
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug interactions with the dopamine transporter in cryopreserved human caudate.
    Eshleman AJ; Wolfrum K; Mash DC; Christensen K; Janowsky A
    J Pharmacol Exp Ther; 2001 Feb; 296(2):442-9. PubMed ID: 11160629
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and pharmacology of site-specific cocaine abuse treatment agents: 2-substituted-6-amino-5-phenylbicyclo[2.2.2]octanes.
    Javanmard S; Deutsch HM; Collard DM; Kuhar MJ; Schweri MM
    J Med Chem; 1999 Nov; 42(23):4836-43. PubMed ID: 10579846
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.